PHARMA MAR, S.A. «12345...» Page 1 out of 18 from 01/07/1988 to 19/10/2024 The price-sensitive information presented in other languages is a literal translation of the price-sensitive information stated in Spanish 22/01/2020 08:21 PHARMA MAR, S.A. R&D: new licenses, patents and registered trademarks Pharma Mar announces fulfillment of the condition consisting on the authorization by the United States antitrust authorities to the exclusive license agreement entered with Jazz Pharmaceuticals. Register number: 286053 Related with 284941 of 19/12/2019 (13:58) 21/01/2020 17:16 PHARMA MAR, S.A. Composition of other management and supervisory bodies The Company informs of the appointment of Mr. Carlos Pazos Campos as a member of the Appointments and Compensation Committee. Register number: 286047 08/01/2020 17:50 PHARMA MAR, S.A. Liquidity contracts and specialists The Company reports details of the operations of the Liquidity Agreement between 01/10/2019 and 31/12/2019 Register number: 285701 Related with 266399 of 04/06/2018 (17:39) 19/12/2019 13:58 PHARMA MAR, S.A. R&D: new licenses, patents and registered trademarks. - Announcements of public presentations and meetings Pharma Mar and Jazz Pharmaceuticals have entered into an exclusive license agreement to commercialize lurbinectedin in the United States. Register number: 284941 Related with 286053 of 22/01/2020 (08:21) 17/12/2019 08:10 PHARMA MAR, S.A. R&D: new licenses, patents and registered trademarks Phama Mar submits New Drug Application for lurbinectedin under accelerated approval in small cell lung cancer in the USA. Register number: 284566 Related with 281246 of 19/08/2019 (08:27) 23/10/2019 18:49 PHARMA MAR, S.A. Composition of other management and supervisory bodies The Company reports the appointment of the Chairman of the Audit Committee. Register number: 282799 23/10/2019 18:32 PHARMA MAR, S.A. Information on P&L The Company sends press release regarding the third quarter 2019 results. Register number: 282796 23/10/2019 18:23 PHARMA MAR, S.A. Interim financial information La sociedad remite información sobre los resultados del tercer trimestre de 2019 Register number: 282795 03/10/2019 17:51 PHARMA MAR, S.A. Liquidity contracts and specialists The Company reports details of the operations of the Liquidity Agreement between 01/07/2019 and 30/09/2019 Register number: 282269 Related with 266399 of 04/06/2018 (17:39) 26/08/2019 08:29 PHARMA MAR, S.A. R&D: new licenses, patents and registered trademarks Pharma Mar and Janssen have entered into a new licensing agreement for Yondelis in US and a master product transfer agreement regarding Yondelis rights in the rest of territories licensed to Janssen. Register number: 281299 Page 1 out of 18 «12345...»